新里程(002219) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 reached ¥805,193,959.15, representing an increase of 8.18% compared to the same period last year[7] - The net profit attributable to shareholders for Q3 2022 was ¥15,462,621.60, a significant increase of 185.56% year-on-year[7] - Basic earnings per share for Q3 2022 were ¥0.0189, reflecting a growth of 456.60% compared to the previous year[7] - Total operating revenue for the current period reached ¥2,326,660,478.27, an increase from ¥2,224,300,970.63 in the previous period, representing a growth of approximately 4.6%[36] - Net profit for the current period was ¥121,283,831.87, a significant recovery from a net loss of ¥57,174,950.52 in the previous period[38] - Basic earnings per share for the current period improved to ¥0.0344, compared to a loss of ¥0.0317 per share in the previous period[38] - The company's total profit for the current period was ¥147,571,758.68, a recovery from a total loss of ¥36,220,327.39 in the previous period[38] Assets and Liabilities - The total assets at the end of Q3 2022 amounted to ¥5,502,832,413.37, a decrease of 17.75% from the end of the previous year[7] - As of September 30, 2022, total assets amounted to ¥5,502,832,413.37, a decrease from ¥6,690,205,812.98 at the beginning of the year, representing a decline of approximately 17.7%[29] - Current assets decreased to ¥1,767,932,569.64 from ¥3,023,848,238.36, indicating a reduction of about 41.5%[29] - Total liabilities decreased to ¥3,794,910,476.50 from ¥5,104,155,707.98, reflecting a decline of approximately 25.7%[31] - The company's short-term borrowings significantly decreased from ¥1,274,371,644.23 to ¥99,850,000.00, a reduction of about 92.2%[31] - The company's total equity increased to ¥1,707,921,936.87 from ¥1,586,050,105.00, showing an increase of approximately 7.6%[31] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥97,923,313.84, down 53.27% year-on-year[7] - Cash flow from operating activities generated a net amount of ¥97,923,313.84, down from ¥209,549,867.80 in the previous period[42] - Cash inflow from operating activities totaled ¥2,332,736,027.28, compared to ¥2,184,543,218.48 in the previous period, reflecting an increase of approximately 6.8%[42] - Cash outflow from operating activities was ¥2,234,812,713.44, up from ¥1,974,993,350.68 in the previous period, indicating an increase of about 13.1%[42] - The net cash flow from financing activities was -1,037,090,264.24, a significant decrease compared to -43,062,707.58 from the previous period[45] - The net increase in cash and cash equivalents was -1,399,542,385.38, contrasting with an increase of 29,689,974.08 previously[45] - The ending balance of cash and cash equivalents was 591,558,206.67, down from 1,991,100,592.05 at the beginning of the period[45] Shareholder Information - Total number of common shareholders at the end of the reporting period was 32,374[20] - The largest shareholder, Beijing New Mileage Health Industry Group Co., Ltd., holds 25.30% of shares, totaling approximately 825.93 million shares[20] Company Changes - The company changed its name from "Hengkang Medical Group Co., LTD" to "New Journey Health Technology Group Co., LTD" effective September 26, 2022[26] Other Financial Metrics - The weighted average return on equity for Q3 2022 was 3.84%, an increase of 13.39% compared to the previous year[7] - The company received government subsidies totaling ¥6,655,762.71 during the quarter, contributing to its non-operating income[8] - Interest expenses increased by 58.29% to approximately $106.21 million compared to the same period last year[16] - Interest income surged by 1775.60$8.28 million due to increased interest from restructured investments[16] - Investment income rose by 237.29% to approximately $11.57 million, attributed to debt forgiveness[16] - Credit impairment losses increased significantly by 2319.25$38.91 million, reflecting recoveries from previous disposals[16] - Tax refunds received increased by 367.44% to approximately $2.73 million compared to the previous year[16] - Cash paid for operating activities rose by 31.40$388.97 million, driven by restructuring costs[16] - Cash received from the disposal of subsidiaries amounted to approximately $42 million, marking a 100$100 million, reflecting bank wealth management redemptions[16]